Ganot Ilan
Known title: CEO & PresidentCIK: 0001727460
Associated companies
Transaction History
| SLDB | ▼ Sell | Open Market | 2,658 | $15K | 2/18/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,861 | — | 2/13/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 7,205 | $46K | 2/4/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 15,000 | — | 1/31/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 191 | $1K | 1/28/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 389 | — | 1/27/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,884 | — | 1/27/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 1,053 | $6K | 1/5/2026 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 2,994 | — | 1/3/2026 | View on chart |
| SLDB | ▼ Sell | Open Market | 3,278 | $14K | 11/10/2025 | View on chart |
| SLDB | ▼ Sell | Open Market | 1,711 | $7K | 2/14/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 4,861 | — | 2/13/2025 | View on chart |
| SLDB | ▼ Sell | Open Market | 144 | $448 | 1/28/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 388 | — | 1/27/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,883 | — | 1/27/2025 | View on chart |
| SLDB | ▼ Sell | Open Market | 1,056 | $5K | 1/6/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 2,994 | — | 1/3/2025 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,553 | — | 5/2/2024 | View on chart |
| SLDB | ▼ Sell | Open Market | 462 | $5K | 5/2/2024 | View on chart |
| SLDB | ▼ Sell | Open Market | 139 | $1K | 1/29/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 388 | — | 1/27/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,883 | — | 1/27/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 2,993 | — | 1/3/2024 | View on chart |
| SLDB | ▼ Sell | Open Market | 1,142 | $6K | 1/3/2024 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,583 | — | 12/2/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,583 | — | 9/2/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,583 | — | 6/2/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,553 | — | 5/2/2023 | View on chart |
| SLDB | ▼ Sell | Open Market | 487 | $2K | 5/2/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 1,584 | — | 3/2/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 388 | — | 1/27/2023 | View on chart |
| SLDB | ▼ Sell | Open Market | 141 | $1K | 1/27/2023 | View on chart |
| SLDB | ▲ Buy | Option Exercise | 3,883 | — | 1/27/2023 | View on chart |
| SLDB | ▼ Sell | Open Market | 1,382 | $10K | 1/27/2023 | View on chart |
| SLDB | ▼ Sell | Open Market | 463 | $519 | 2/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SLDB Featured in After-Market Movers List
Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.
SLDB Featured in After-Market Movers List. Solid Biosciences was included in a Benzinga list of healthcare stocks moving in Friday's after-market session. The stock is currently trading near its 52-week low, with an RSI of 20.5 indicating oversold conditions. Analysts maintain an average price target of $18.62, which is significantly higher than the current trading range.